Jakob T. Sieker

Jakob T. Sieker

Auto-generated profile, based on publicly available information

Jakob T. Sieker

<!--12--> Department of Orthopedic Surgery, Boston Children’s Hospital Harvard Medical School Boston MA USA

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 February 2016 in Arthritis & Rheumatology
Verified
Journal Article
Open access
PDF file
JSJakob T. Sieker
Jakob T. Sieker
UAUgur M. Ayturk
Ugur M. Ayturk
BPBenedikt L. Proffen
Benedikt L. Proffen
MWManuela H. Weissenberger
Manuela H. Weissenberger
AKAta M. Kiapour
Ata M. Kiapour
MMMartha M. Murray
Martha M. Murray
Objective: To test whether intraarticular corticosteroid injection mitigates injury‐induced synovitis and collagen degradation after anterior cruciate ligament transection (ACLT) and to characterize the synovial response using a functional genomics approach in a preclinical model of posttraumatic osteoarthritis.Methods: Yorkshire pigs underwent unilateral ACLT without subsequent corticosteroid injection (the ACLT group; n = 6) or ACLT with immediate injection of 20 mg triamcinolone acetonide (the steroid group; n = 6). A control group of pigs (the intact group; n = 6) did not undergo surgery. Total synovial membrane cellularity and synovial fluid concentration of C1,2C neoepitope–bearing collagen fragments 14 days after injury were primary end points and were compared between the ACLT, steroid, and intact groups. Cells were differentiated by histologic phenotype and counted, while RNA sequencing was used to quantify transcriptome‐wide gene expression and monocyte, macrophage, and lymphocyte markers.Results: In the intact group, total cellularity was 13% (95% confidence interval [95% CI] 9–16) and the C1,2C concentration was 0.24 μg/ml (95% CI 0.08–0.39). In the ACLT group, significant increases were observed in total cellularity (to 21% [95% CI 16–27]) and C1,2C concentration (to 0.49 μg/ml [95% CI 0.39–0.59]). Compared to values in the ACLT group, total cellularity in the steroid group was nonsignificantly decreased to 17% (95% CI 15–18) (P = 0.26) and C1,2C concentration in the steroid group was significantly decreased to 0.29 μg/ml (95% CI 0.23–0.35) (P = 0.04). A total of 255 protein‐coding transcripts were differentially expressed between the ACLT group and the intact group. These genes mainly enriched pathways related to cellular immune response, proteolysis, and angiogenesis. Mononuclear leukocytes were the dominant cell type in cell‐dense areas. MARCO, SOCS3, CCR1, IL4R, and MMP2 expression was significantly associated with C1,2C levels.Conclusion: Early intraarticular immunosuppression mitigated injury‐induced increases in collagen fragments, an outcome better predicted by specific marker expression than by histologic measures of synovitis.

1 March 2015 in Osteoarthritis and Cartilage
Verified
Journal Article
Closed access
JSJ.T. Sieker
J.T. Sieker
MKM. Kunz
M. Kunz
WMWeißenberger Manuel
Weißenberger Manuel
FGF. Gilbert
F. Gilbert
SFS. Frey
S. Frey
ASAndre F. Steinert
Andre F. Steinert

29 December 2017 in Journal of Orthopaedic Research
Verified
Journal Article
Closed access
PDF file
JBJillian E Beveridge
Jillian E Beveridge
JMJason T. Machan
Jason T. Machan
EWEdward G. Walsh
Edward G. Walsh
AKAta M. Kiapour
Ata M. Kiapour
NKNaga Padmini Karamchedu
Naga Padmini Karamchedu
BFBraden C Fleming
Braden C Fleming

3 July 2017 in Journal of Orthopaedic Research
Verified
Journal Article
Open access
PDF file
JSJakob T. Sieker
Jakob T. Sieker
BPBenedikt L. Proffen
Benedikt L. Proffen
KWKimberly A. Waller
Kimberly A. Waller
KCKaitlyn E. Chin
Kaitlyn E. Chin
NKNaga Padmini Karamchedu
Naga Padmini Karamchedu
BFBraden C Fleming
Braden C Fleming
To identify the molecular pathophysiology present in early post‐traumatic osteoarthritis (PTOA), the transcriptional profile of articular cartilage and its response to surgical PTOA induction were determined. Thirty six Yucatan minipigs underwent anterior cruciate ligament (ACL) transection and were randomly assigned in equal numbers to no further treatment, reconstruction or ligament repair. Cartilage was harvested at 1 and 4 weeks post‐operatively and histology and RNA‐sequencing were performed and compared to controls. Microscopic cartilage scores significantly worsened at 1 (p = 0.028) and 4 weeks (p = 0.001) post‐surgery relative to controls, but did not differ between untreated, reconstruction or repair groups. Gene expression after ACL reconstruction and ACL transection were similar, with only 0.03% (includingSERPINB7andCR2) and 0.2% of transcripts (includingINHBA) differentially expressed at 1 and 4 weeks respectively.COL2A1,COMP,SPARC,CHAD, andEF1ALPHAwere the most highly expressed non ribosomal, non mitochondrial genes in the controls and remained abundant after surgery. A total of 1,275 genes were differentially expressed between 1 and 4 weeks post‐surgery. With the treatment groups pooled, 682 genes were differentially expressed at both time‐points, with the most significant changes observed inMMP1,COCH,POSTN,CYTL1, andPTGFR. This study confirmed the development of a microscopic PTOA stage after ACL surgery in the porcine model. Upregulation of multiple proteases (includingMMP1andADAMTS4) were found; however, the level of expression remained orders of magnitude below that of extracellular matrix protein‐coding genes (includingCOL2A1andACAN). In summary, genes with established roles in PTOA as well as novel targets for specific intervention were identified. © 2017 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 36:318–329, 2018.

20 April 2018 in Journal of Orthopaedic Research
Verified
Journal Article
Closed access
PDF file
JSJakob T. Sieker
Jakob T. Sieker
BPBenedikt L. Proffen
Benedikt L. Proffen
KWKimberly A. Waller
Kimberly A. Waller
KCKaitlyn E. Chin
Kaitlyn E. Chin
NKNaga Padmini Karamchedu
Naga Padmini Karamchedu
MMMartha Murray
Martha Murray

18 June 2015 in Journal of Biomaterials Applications
Verified
Journal Article
Closed access
PDF file
BPBenedikt L Proffen
Benedikt L Proffen
GPGabriel S Perrone
Gabriel S Perrone
BFBraden C Fleming
Braden C Fleming
JSJakob T Sieker
Jakob T Sieker
JKJoshua Kramer
Joshua Kramer
MMMartha Murray
Martha Murray
Reconstituted extracellular matrix (ECM)-derived scaffolds are commonly utilized in preclinical tissue engineering studies as delivery vehicles for cells and growth factors. Translation into clinical use requires identifying a sterilization method that effectively removes bacteria but does not harm scaffold function. To determine effectiveness of sterilization and impact on ECM scaffold integrity and function, low-temperature ethylene oxide and 15 kGy electron beam irradiation techniques were evaluated. Scaffold sterility was assessed in accordance to United States Pharmacopeia Chapter 71. Scaffold matrix degradation was determined in vitro using enzymatic resistance tests and gel electrophoresis. Scaffold mechanics including elastic modulus, yield stress and collapse modulus were tested. Lastly, 14 Yorkshire pigs underwent ACL transection and bio-enhanced ACL repair using sterilized scaffolds. Histologic response of ligament, synovium, and lymph nodes was compared at 4, 6, and 8 weeks. Ethylene oxide as well as electron beam irradiation yielded sterile scaffolds. Scaffold resistance to enzymatic digestion and protein integrity slightly decreased after electron beam irradiation while ethylene oxide altered scaffold matrix. Scaffold elastic modulus and yield stress were increased after electron beam treatment, while collapse modulus was increased after ethylene oxide treatment. No significant changes in ACL dimensions, in vivo scaffold resorption rate, or histologic response of synovium, ligament, and lymph nodes with either terminal sterilization technique were detectable. In conclusion, this study identifies two methods to terminally sterilize an ECM scaffold. In vitro scaffold properties were slightly changed without significantly influencing the biologic responses of the surrounding tissues in vivo. This is a critical step toward translating new tissue engineering strategies to clinical trials.